Erythropoiesis-stimulating Agents and Anemia in Patients with Non-dialytic Chronic Kidney Disease

Anemia is common in patients with advanced chronic kidney disease (CKD). Though erythropoiesis-stimulating agents (ESAs) have been strongly endorsed in guidelines, it is of particular financial interest. Recently, the reimbursement of ESAs in non-dialytic patients was started by the Korean National...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sun Moon, Kim, Kyeong Min, Kwon, Soon Kil, Kim, Hye-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712580/
https://www.ncbi.nlm.nih.gov/pubmed/26770038
http://dx.doi.org/10.3346/jkms.2016.31.1.55

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712580/
https://www.ncbi.nlm.nih.gov/pubmed/26770038
http://dx.doi.org/10.3346/jkms.2016.31.1.55

Ejemplares similares